| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.03 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.081 | 0.03 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.03 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.03 |